Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. Abstract Text:

Lauri A Hicks,Lee H Harrison,Brendan Flannery,James L Hadler,William Schaffner,Allen S Craig,Delois Jackson,Ann Thomas,Bernard Beall,Ruth Lynfield,Arthur Reingold,Monica M Farley,Cynthia G Whitney,Lauri A Hicks,Lee H Harrison,Brendan Flannery,James L Hadler,William Schaffner,Allen S Craig,Delois Jackson,Ann Thomas,Bernard Beall,Ruth Lynfield,Arthur Reingold,Monica M Farley,Cynthia G Whitney,Lauri A Hicks,Lee H Harrison,Brendan Flannery,James L Hadler,William Schaffner,Allen S Craig,Delois Jackson,Ann Thomas,Bernard Beall,Ruth Lynfield,Arthur Reingold,Monica M Farley,Cynthia G Whitney,

BACKGROUND: Widespread use of pneumococcal conjugate vaccine (PCV7) resulted in decreases in invasive disease among children and elderly persons. The benefits may be offset by increases in disease due to serotypes not included in the vaccine (hereafter, "nonvaccine serotypes"). We evaluated the effect of PCV7 on incidence of disease due to nonvaccine serotypes. METHODS: Cases of invasive disease were identified in 8 geographic areas through the Centers for Disease Control and Prevention's Active Bacterial Core surveillance. Serotyping and susceptibility testing of isolates were performed. We calculated the incidence of disease for children aged <5 years and adults aged > or =65 years. We compared rates of serotype-specific disease before and after PCV7 was licensed for use. RESULTS: The annual incidence of disease due to nonvaccine serotypes increased from an average of 16.3 cases/100,000 population during prevaccine years (1998-1999) to 19.9 cases/100,000 population in 2004 for children aged <5 years (P=.01) and from 27.0 cases/100,000 population during prevaccine years to 29.8 cases/100,000 population in 2004 for adults aged > or =65 years (P=.05). Significant increases in the incidences of disease due to serotypes 3, 15, 19A, 22F, and 33F were observed among children during this period (P<.05 for each serotype); serotype 19A has become the predominant cause of invasive disease in children. The incidence of disease due to these serotypes also increased among elderly persons. CONCLUSIONS: The incidence of pneumococcal disease caused by nonvaccine serotypes is increasing. Ongoing surveillance is needed to monitor the magnitude of disease caused by nonvaccine serotypes, to ensure that future vaccines target the appropriate serotypes.

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. Publishing Authors By Initials

LA Hicks,LH Harrison,B Flannery,JL Hadler,W Schaffner,AS Craig,D Jackson,A Thomas,B Beall,R Lynfield,A Reingold,MM Farley,CG Whitney,LA Hicks,LH Harrison,B Flannery,JL Hadler,W Schaffner,AS Craig,D Jackson,A Thomas,B Beall,R Lynfield,A Reingold,MM Farley,CG Whitney,LA Hicks,LH Harrison,B Flannery,JL Hadler,W Schaffner,AS Craig,D Jackson,A Thomas,B Beall,R Lynfield,A Reingold,MM Farley,CG Whitney,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: The Journal of infectious diseases

VOLUME: 196

Page Numbers: 1346-54

Journal Abbreviation: J. Infect. Dis.

ISSN: 0022-1899

DAY: 4

MONTH: 10

YEAR: 2007

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 413675

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

AFFILIATION: Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. lhicks@cdc.gov

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Infect Dis

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine PCV7 serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004 Related Publications

• A PRELIMINARY INVESTIGATION OF THE PHARMACOLOGY OF THE HUMAN ISOLATED TAENIA COLI PREPARATION.
• Absorption and distribution of salicylamide.
• Bleeding per-ano.
• Consent: informed, simple, implied and presumed.
• Correlates of physical activity in adults with mobility limitations.
• Editorial Commentary: Emergence of Nonvaccine Serotypes following Introduction of Pneumococcal Conjugate Vaccine: Cause and Effect?
• Holistic crowding: selective interference between configural representations of faces in crowded scenes.
• Homonymous Hemianopia: A Critical Analysis of Optical Devices, Compensatory Training, and NovaVision.
• Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.
• Medication administration variances before and after implementation of computerized physician order entry in a neonatal intensive care unit.
• Medications for Parkinson's disease.
• Mental deficiency in the 1880's and 1940's; a brief review of 60 years' progress.
• Official Reporting of Childhood Type of Tuberculosis.
• Pathological findings in dogs naturally infected with Angiostrongylus vasorum in Newfoundland and Labrador, Canada.
• Position shifts following crowded second-order motion adaptation reveal processing of local and global motion without awareness.
• Rapid extraction of mean emotion and gender from sets of faces.
• Risk factors for invasive pneumococcal disease among Navajo adults.
• SAFETY FOR MORE AND BETTER ADVENTURES.
• Shared attentional resources for global and local motion processing.
• Some Concrete Problems of Health Administration-A Symposium: Health Coördination in New Orleans.
• Study of Urban and Rural Tuberculosis Death Rates in New York State.
• Symposium-"What Every Health Officer Should Know": Vital Statistics.
• THE TELEPHONE REFLECTS YOU.
• THE TREATMENT OF ROOMS AFTER DIPHTHERIA AND SCARLET FEVER.
• The catalytic properties of hybrid rubisco comprising tobacco small and sunflower large subunits mirror the kinetically equivalent source rubiscos and can support tobacco growth.
• The historical approach to the subject of mental retardation.
• The one that didn't get away.
• The pathology and therapy of frost-bite.
• Tongue tip overfolding.
• Uncovering pneumococcal disease burden in bangladesh.